Our findings indicated that elevated levels of MKLN1-AS in PDAC act as a competitive endogenous RNA (ceRNA) by interacting with miR-185-5p, resulting in enhanced cell proliferation, migration, and tumor development through the modulation of TEAD1 expression. The gene discussed is TEAD1; the disease is neoplasm.